Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

Collin K. Chin,Maria Alma Rodriguez,Yun Qing,Lei Feng,Felipe Samaniego,Preetesh Jain,Mansoor Noorani,Nathan Fowler,Luis Fayad,Jason R. Westin,Sattva S. Neelapu,Frederick Hagemeister,Christopher R. Flowers,Loretta J. Nastoupil

Leukemia & Lymphoma（2020）

Cited 2|Views5

No score

Abstract

Histologic transformation of indolent lymphomas account for 13% of de novo presentations of diffuse large B-cell lymphoma (DLBCL) [1]. Although historically associated with poor outcomes in compari...

Translated text

Key words

cell lymphoma,maintenance rituximab

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined